Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration

Kakarla V. Chalam; Sandeep Grover; Kumar Sambhav; Sankarathi Balaiya; Ravi K. Murthy

doi:10.1155/2014/502174

Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration

Kakarla V. Chalam, Sandeep Grover, Kumar Sambhav, Sankarathi Balaiya, Ravi K. Murthy

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	502174
Journal	Journal of Ophthalmology
Volume	2014
DOIs	https://doi.org/10.1155/2014/502174
State	Published - 2014

ASJC Scopus Subject Areas

Ophthalmology

Access to Document

10.1155/2014/502174

OpenUrl availability

Full text

Cite this

@article{b281f0651e254f26afb75180f83b4f72,

title = "Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration",

author = "Chalam, {Kakarla V.} and Sandeep Grover and Kumar Sambhav and Sankarathi Balaiya and Murthy, {Ravi K.}",

year = "2014",

doi = "10.1155/2014/502174",

language = "English",

volume = "2014",

journal = "Journal of Ophthalmology",

issn = "2090-004X",

}

TY - JOUR

T1 - Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration

AU - Chalam, Kakarla V.

AU - Grover, Sandeep

AU - Sambhav, Kumar

AU - Balaiya, Sankarathi

AU - Murthy, Ravi K.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84904616437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904616437&partnerID=8YFLogxK

U2 - 10.1155/2014/502174

DO - 10.1155/2014/502174

M3 - Article

AN - SCOPUS:84904616437

SN - 2090-004X

VL - 2014

JO - Journal of Ophthalmology

JF - Journal of Ophthalmology

M1 - 502174

ER -

Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this